Sarcoidosis among hospitalized patients in Poland: a study based on a national hospital registry.
暂无分享,去创建一个
P. Goryński | A. Nitsch-Osuch | K. Kanecki | P. Tyszko | A. Barańska | Magdalena Bogdan | P. Samel-Kowalik
[1] K. Roszkowski-Śliż,et al. Systemic treatment for sarcoidosis was needed for 16% of 1810 Caucasian patients , 2018, The clinical respiratory journal.
[2] I. Annesi-Maesano,et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris , 2017, European Respiratory Journal.
[3] A. White,et al. Economic burden of sarcoidosis in a commercially-insured population in the United States , 2017, Journal of medical economics.
[4] F. Bonella,et al. Epidemiologie und klinisches Erscheinungsbild der Sarkoidose , 2016, Klinische Monatsblätter für Augenheilkunde.
[5] E. Matteson,et al. Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. , 2017, Reumatismo.
[6] A. Ćmiel,et al. Endosonography‑guided fine‑needle aspiration in the diagnosis of sarcoidosis: a randomized study. , 2017, Polish archives of internal medicine.
[7] E. Matteson,et al. Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976–2013 , 2017, Lung.
[8] E. Matteson,et al. Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study. , 2016, Respiratory medicine.
[9] E. Matteson,et al. Seasonal variation in incidence of sarcoidosis: a population-based study, 1976–2013 , 2016, Thorax.
[10] J. Grunewald,et al. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden , 2016, European Respiratory Journal.
[11] M. Brutsche,et al. In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 , 2016, PloS one.
[12] K. Roszkowski-Śliż,et al. What comorbidities accompany sarcoidosis? A large cohort (n=1779) patients analysis. , 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[13] P. Kawalec,et al. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland , 2015, Expert review of pharmacoeconomics & outcomes research.
[14] M. Szczyrek,et al. The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings , 2015, Archives of medical science : AMS.
[15] P. Spagnolo. Sarcoidosis: a Critical Review of History and Milestones , 2015, Clinical Reviews in Allergy & Immunology.
[16] M. Nørgaard,et al. Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study , 2014, European Respiratory Journal.
[17] A. Prasse,et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[18] J. Zejda,et al. Epidemiology of sarcoidosis recorded in 2006-2010 in the Silesian voivodeship on the basis of routine medical reporting. , 2014, Annals of agricultural and environmental medicine : AAEM.
[19] P. Polgreen,et al. An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007. , 2012, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[20] V. Cottin,et al. Late-Onset Sarcoidosis: A Comparative Study , 2012, Medicine.
[21] Kira L. Newman,et al. Occupational causes of sarcoidosis , 2012, Current opinion in allergy and clinical immunology.
[22] D. Prezant,et al. Sarcoidosis Diagnosed After September 11, 2001, Among Adults Exposed to the World Trade Center Disaster , 2011, Journal of occupational and environmental medicine.
[23] Joseph H Abramson,et al. WINPEPI updated: computer programs for epidemiologists, and their teaching potential , 2011, Epidemiologic perspectives & innovations : EP+I.
[24] Ragnar Rylander,et al. Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study , 2011, Environmental health : a global access science source.
[25] C. Schindler,et al. Prevalence of sarcoidosis in Switzerland is associated with environmental factors , 2009, European Respiratory Journal.
[26] M. Olesińska,et al. Sarcoidosis: selected clinical cases. , 2009, Polskie Archiwum Medycyny Wewnetrznej.
[27] T. Karayel,et al. Seasonality of the onset of symptoms, Tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis , 2007, Respirology.
[28] G. McLennan,et al. Job and Industry Classifications Associated With Sarcoidosis in a Case–Control Etiologic Study of Sarcoidosis (ACCESS) , 2005, Journal of occupational and environmental medicine.
[29] G. McLennan,et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. , 2004, American journal of respiratory and critical care medicine.
[30] J. Tekavec-Trkanjec,et al. Prevalence of hospitalized patients with sarcoidosis in Croatia. , 2004, Collegium antropologicum.
[31] M. Yamaguchi,et al. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. , 1995, Sarcoidosis.
[32] R. Baughman,et al. Predictors of Mortality in Pulmonary Sarcoidosis , 2018, Chest.
[33] G. Hoser,et al. Th1/Th2/Th17‑related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking. , 2012, Polskie Archiwum Medycyny Wewnetrznej.
[34] J. Kozielski,et al. [Change of patients profile hospitalized because of pulmonary sarcoidosis in Department of Pneumonology in Zabrze (Poland) in 1976-80 and in 1996-2000]. , 2005, Pneumonologia i alergologia polska.
[35] M. Pérez-Simón,et al. [Sarcoidosis in a sanitary area at Leon (Spain). Epidemiology and clinical features]. , 2003, Anales de medicina interna.